• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癸酸氟奋乃静的血浆水平。注射部位、按摩及肌肉活动的影响。

Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.

作者信息

Soni S D, Wiles D, Schiff A A, Bamrah J S

机构信息

Psychiatric Research Department, Salford Health Authority, Prestwich Hospital, Manchester.

出版信息

Br J Psychiatry. 1988 Sep;153:382-4. doi: 10.1192/bjp.153.3.382.

DOI:10.1192/bjp.153.3.382
PMID:3250675
Abstract

Depot neuroleptics are now commonly used for maintenance therapy of schizophrenia. Their physicochemical composition makes them ideal for such use because they are long-acting and show stable blood levels for prolonged periods. Their absorption from the site of injection may, however, be affected by local muscle factors. This paper describes three such factors in relation to fluphenazine decanoate: varying the site of injection; massage of the injection site; and effects of muscular exercise. Our results suggest that fluphenazine pharmacokinetics are not significantly affected by any of these factors.

摘要

长效抗精神病药物目前常用于精神分裂症的维持治疗。它们的物理化学组成使其非常适合这种用途,因为它们作用时间长,且在较长时间内血药浓度稳定。然而,它们从注射部位的吸收可能会受到局部肌肉因素的影响。本文描述了与癸酸氟奋乃静相关的三个这样的因素:改变注射部位;按摩注射部位;以及肌肉运动的影响。我们的结果表明,这些因素均未对氟奋乃静的药代动力学产生显著影响。

相似文献

1
Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.癸酸氟奋乃静的血浆水平。注射部位、按摩及肌肉活动的影响。
Br J Psychiatry. 1988 Sep;153:382-4. doi: 10.1192/bjp.153.3.382.
2
Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.在使用癸酸氟奋乃静进行长期治疗期间监测血浆中氟奋乃静的水平。
J Clin Pharm Ther. 1995 Apr;20(2):55-62. doi: 10.1111/j.1365-2710.1995.tb00629.x.
3
Low neuroleptic serum levels in patients receiving fluphenazine decanoate.接受癸酸氟奋乃静治疗的患者中抗精神病药物血清水平较低。
Am J Psychiatry. 1980 Jan;137(1):80-2. doi: 10.1176/ajp.137.1.80.
4
Depot fluphenazine decanoate and enanthate for schizophrenia.用于治疗精神分裂症的癸酸氟奋乃静和庚酸氟奋乃静长效注射剂
Cochrane Database Syst Rev. 2005 Jan 25(1):CD000307. doi: 10.1002/14651858.CD000307.
5
Plasma levels of neuroleptic in patients receiving depot fluphenazine.接受长效氟奋乃静治疗的患者的血浆中抗精神病药物水平。
J Clin Psychopharmacol. 1985 Dec;5(6):328-32.
6
Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.采用放射免疫分析法测定接受氟奋乃静癸酸酯长效注射治疗的精神分裂症患者的血浆氟奋乃静水平。
Adv Biochem Psychopharmacol. 1980;24:599-602.
7
Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.用癸酸氟奋乃静治疗的慢性精神分裂症患者复发与血清抗精神病药物水平低有关。
J Clin Psychiatry. 1986 May;47(5):247-8.
8
Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.通过放射受体分析法测定接受肌肉注射长效抗精神病药物患者的抗精神病药物血清水平。一些初步发现。
Br J Psychiatry. 1985 Apr;146:439-42. doi: 10.1192/bjp.146.4.439.
9
Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.癸酸氟哌啶醇替代癸酸氟奋乃静进行精神分裂症及其他慢性精神病的维持治疗。
Acta Psychiatr Belg. 1982 Mar-Apr;82(2):216-23.
10
Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.采用放射免疫分析法测定接受氟奋乃静癸酸酯长效注射治疗的精神分裂症患者的血浆氟奋乃静水平。
Br J Clin Pharmacol. 1979 Dec;8(6):565-70. doi: 10.1111/j.1365-2125.1979.tb01045.x.

引用本文的文献

1
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.长效注射抗精神病药治疗精神分裂症的药代动力学特征:综述。
CNS Drugs. 2021 Jan;35(1):39-59. doi: 10.1007/s40263-020-00779-5. Epub 2021 Jan 28.